Log in to save to my catalogue

Biological and clinical consequences of NPM1 mutations in AML

Biological and clinical consequences of NPM1 mutations in AML

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1891855142

Biological and clinical consequences of NPM1 mutations in AML

About this item

Full title

Biological and clinical consequences of NPM1 mutations in AML

Publisher

London: Nature Publishing Group UK

Journal title

Leukemia, 2017-04, Vol.31 (4), p.798-807

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Acute myeloid leukemia (AML) is characterized by accumulation of myeloid cells in the bone marrow because of impaired differentiation and proliferation, resulting in hematopoietic insufficiency.
NPM1
is one of the most commonly mutated genes in AML, present in 20–30% of cases. Mutations in
NPM1
represent a distinct entity in the World H...

Alternative Titles

Full title

Biological and clinical consequences of NPM1 mutations in AML

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1891855142

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1891855142

Other Identifiers

ISSN

0887-6924

E-ISSN

1476-5551

DOI

10.1038/leu.2017.30

How to access this item